STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells

Jong Wook Kim(Broad Institute), Christian Berrios(Boston University), Mi‐Ju Kim(Broad Institute), Amy E. Schade(Boston University), Guillaume Adelmant(Boston University), Huwate Yeerna(University of California San Diego Medical Center), Emily Damato(Broad Institute), Amanda Balboni Iniguez(Broad Institute), Laurence Florens(Stowers Institute for Medical Research), Michael P. Washburn(Stowers Institute for Medical Research), Kim Stegmaier(Broad Institute), Nathanael S. Gray(Boston University), Pablo Tamayo(University of California San Diego), Ole Gjoerup(Boston University), Jarrod A. Marto(Boston University), James A. DeCaprio(Boston University), William C. Hahn(Broad Institute)
eLife
January 8, 2020
Cited by 60Open Access
Full Text

Abstract

Alterations involving serine-threonine phosphatase PP2A subunits occur in a range of human cancers, and partial loss of PP2A function contributes to cell transformation. Displacement of regulatory B subunits by the SV40 Small T antigen (ST) or mutation/deletion of PP2A subunits alters the abundance and types of PP2A complexes in cells, leading to transformation. Here, we show that ST not only displaces common PP2A B subunits but also promotes A-C subunit interactions with alternative B subunits (B''', striatins) that are components of the Striatin-interacting phosphatase and kinase (STRIPAK) complex. We found that STRN4, a member of STRIPAK, is associated with ST and is required for ST-PP2A-induced cell transformation. ST recruitment of STRIPAK facilitates PP2A-mediated dephosphorylation of MAP4K4 and induces cell transformation through the activation of the Hippo pathway effector YAP1. These observations identify an unanticipated role of MAP4K4 in transformation and show that the STRIPAK complex regulates PP2A specificity and activity.


Related Papers

No related papers found

Powered by citation graph analysis